24 May 2012: Enclosed you will find the Q1-2012 report for NorDiag ASA. In addition the Company refers to press release of May 4, 2012 regarding sale of assets.

For further information, please contact:
Hans Hekland, Phone: +47 906 26 870

About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and reagents) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The Company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The Company has offices and laboratories in Stockholm, Sweden and in Atlanta (GA), USA. The group has today 31.6 man-labour years. NorDiag is listed on the Oslo Stock Exchange with ticker NORD.

Q1 2012 Report

Read the notice in Norwegian here.